Loading…

Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS

Nonalcoholic fatty liver (NAFLD) is associated with metabolic abnormalities and changes in lipid processing. Fatty acids (FAs) are important signaling molecules in the body and are the main raw materials for lipid synthesis. To explore the lipidomic profile of serum fatty acids in mice, we put the m...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical and biomedical analysis 2022-03, Vol.211, p.114620-114620, Article 114620
Main Authors: Yan, Xing, Li, Linnan, Liu, Pei, Xu, Jie, Wang, Zhengtao, Ding, Lili, Yang, Li
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-8eb26e2d69058c70b5beac23116b0431f44b694a170a490a5131a2aac841ea1e3
cites cdi_FETCH-LOGICAL-c356t-8eb26e2d69058c70b5beac23116b0431f44b694a170a490a5131a2aac841ea1e3
container_end_page 114620
container_issue
container_start_page 114620
container_title Journal of pharmaceutical and biomedical analysis
container_volume 211
creator Yan, Xing
Li, Linnan
Liu, Pei
Xu, Jie
Wang, Zhengtao
Ding, Lili
Yang, Li
description Nonalcoholic fatty liver (NAFLD) is associated with metabolic abnormalities and changes in lipid processing. Fatty acids (FAs) are important signaling molecules in the body and are the main raw materials for lipid synthesis. To explore the lipidomic profile of serum fatty acids in mice, we put the mice on a high-fat diet (HFD) to induce NAFLD. We applied a targeted metabolic analysis approach using gas chromatography-mass spectrometry (GC-MS) and established a method for simultaneous determination of 36 medium and long-chain fatty acids in the serum of mice. This method was validated for linearity, range, sensitivity, precision, accuracy, recovery, stability, and dilution integrity. The levels of most FA species and total FAs were increased in the HFD group (n = 9) compared with the lean group (n = 9). The principal component analysis (PCA) and the orthogonal partial least squares discriminant analysis (OPLS-DA) of all FA species were analyzed in both groups. We found that palmitic acid (16:0), stearic acid (18:0), oleic acid (18:1), and arachidonic acid (20:4) were significantly different (VIP>1, p<0.05 and FC>1.5) in the two groups. We also calculated serum indices measure the activities of different enzymes involved in fatty acid metabolism. The de novo lipogenesis index, elongase index, n-6 FAs, saturated FAs, unsaturated FAs, and SCD1 index 2 were increased in the HFD group compared with the lean group while the n-3 FAs, n-3/n-6 of the index, and SCD1 index 1 were decreased in the HFD group compared with the lean group. Relationships between major FA species and biochemical indicators (LDL-C, TC, TG, ALT, and AST) were evaluated by Pearson analysis. The serum FA concentrations (C16:0, C18:0, C18:1, and C20:4) and serum indices (De novo lipogenesis index, elongase index, saturated FAs, unsaturated FAs and n-6 FAs) positively correlated with LDL-C, TC, TG, ALT, and AST. Collectively, our study provides insights into NAFLD and its effect on lipid metabolism. [Display omitted] •A targeted metabolomic method for determination of 36 FAs in serum was established by GC-MS.•Serum concentrations of major FA species and indices are higher in NAFLD compared to controls.•C16:0, C18:0, C18:1, and C20:4 were served as potential biomarkers for differentiating NAFLD from control group.•The level of major FA species and indices in serum positively correlates with LDL-C, TC, TG, ALT and AST.
doi_str_mv 10.1016/j.jpba.2022.114620
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2626223093</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708522000413</els_id><sourcerecordid>2626223093</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-8eb26e2d69058c70b5beac23116b0431f44b694a170a490a5131a2aac841ea1e3</originalsourceid><addsrcrecordid>eNp9kDGP1DAQhS0E4paDP0CBXNJk8diOk0g0aOHukA5RcEh01tiZgFdJvNjJSfvv8WoXSjTFNN970vsYew1iCwLMu_12f3C4lULKLYA2UjxhG2gbVUmjfzxlG9EoqBrR1lfsRc57IUQNnX7OrlQNUmttNuzwgOknLdTziRZ0cYxT8JkfUhzCSJlnSuvEB1yWI0cf-szdkd_dfORh7ldfYnOcKxx9_BXH4C_gGB4pFYKXLuIOc-HizG931ZdvL9mzAcdMry7_mn2_-fSwu6vuv95-3n24r7yqzVK15KQh2ZtO1K1vhKsdoZcKwDihFQxaO9NphEag7gTWoAAlom81EAKpa_b23Fum_F4pL3YK2dM44kxxzVaaclKJThVUnlGfYs6JBntIYcJ0tCDsybTd25NpezJtz6ZL6M2lf3UT9f8if9UW4P0ZoLLyMVCy2Qeai7OQyC-2j-F__X8A_zmOmA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2626223093</pqid></control><display><type>article</type><title>Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS</title><source>ScienceDirect Journals</source><creator>Yan, Xing ; Li, Linnan ; Liu, Pei ; Xu, Jie ; Wang, Zhengtao ; Ding, Lili ; Yang, Li</creator><creatorcontrib>Yan, Xing ; Li, Linnan ; Liu, Pei ; Xu, Jie ; Wang, Zhengtao ; Ding, Lili ; Yang, Li</creatorcontrib><description>Nonalcoholic fatty liver (NAFLD) is associated with metabolic abnormalities and changes in lipid processing. Fatty acids (FAs) are important signaling molecules in the body and are the main raw materials for lipid synthesis. To explore the lipidomic profile of serum fatty acids in mice, we put the mice on a high-fat diet (HFD) to induce NAFLD. We applied a targeted metabolic analysis approach using gas chromatography-mass spectrometry (GC-MS) and established a method for simultaneous determination of 36 medium and long-chain fatty acids in the serum of mice. This method was validated for linearity, range, sensitivity, precision, accuracy, recovery, stability, and dilution integrity. The levels of most FA species and total FAs were increased in the HFD group (n = 9) compared with the lean group (n = 9). The principal component analysis (PCA) and the orthogonal partial least squares discriminant analysis (OPLS-DA) of all FA species were analyzed in both groups. We found that palmitic acid (16:0), stearic acid (18:0), oleic acid (18:1), and arachidonic acid (20:4) were significantly different (VIP>1, p<0.05 and FC>1.5) in the two groups. We also calculated serum indices measure the activities of different enzymes involved in fatty acid metabolism. The de novo lipogenesis index, elongase index, n-6 FAs, saturated FAs, unsaturated FAs, and SCD1 index 2 were increased in the HFD group compared with the lean group while the n-3 FAs, n-3/n-6 of the index, and SCD1 index 1 were decreased in the HFD group compared with the lean group. Relationships between major FA species and biochemical indicators (LDL-C, TC, TG, ALT, and AST) were evaluated by Pearson analysis. The serum FA concentrations (C16:0, C18:0, C18:1, and C20:4) and serum indices (De novo lipogenesis index, elongase index, saturated FAs, unsaturated FAs and n-6 FAs) positively correlated with LDL-C, TC, TG, ALT, and AST. Collectively, our study provides insights into NAFLD and its effect on lipid metabolism. [Display omitted] •A targeted metabolomic method for determination of 36 FAs in serum was established by GC-MS.•Serum concentrations of major FA species and indices are higher in NAFLD compared to controls.•C16:0, C18:0, C18:1, and C20:4 were served as potential biomarkers for differentiating NAFLD from control group.•The level of major FA species and indices in serum positively correlates with LDL-C, TC, TG, ALT and AST.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/j.jpba.2022.114620</identifier><identifier>PMID: 35124446</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Animals ; Diet, High-Fat - adverse effects ; Fatty acids ; Fatty Acids - metabolism ; Gas Chromatography-Mass Spectrometry ; GC-MS ; Lipid metabolism ; Liver - metabolism ; Metabolomics ; Mice ; Non-alcoholic fatty liver ; Non-alcoholic Fatty Liver Disease - etiology ; Non-alcoholic Fatty Liver Disease - metabolism</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 2022-03, Vol.211, p.114620-114620, Article 114620</ispartof><rights>2022</rights><rights>Copyright © 2022. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-8eb26e2d69058c70b5beac23116b0431f44b694a170a490a5131a2aac841ea1e3</citedby><cites>FETCH-LOGICAL-c356t-8eb26e2d69058c70b5beac23116b0431f44b694a170a490a5131a2aac841ea1e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35124446$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yan, Xing</creatorcontrib><creatorcontrib>Li, Linnan</creatorcontrib><creatorcontrib>Liu, Pei</creatorcontrib><creatorcontrib>Xu, Jie</creatorcontrib><creatorcontrib>Wang, Zhengtao</creatorcontrib><creatorcontrib>Ding, Lili</creatorcontrib><creatorcontrib>Yang, Li</creatorcontrib><title>Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>Nonalcoholic fatty liver (NAFLD) is associated with metabolic abnormalities and changes in lipid processing. Fatty acids (FAs) are important signaling molecules in the body and are the main raw materials for lipid synthesis. To explore the lipidomic profile of serum fatty acids in mice, we put the mice on a high-fat diet (HFD) to induce NAFLD. We applied a targeted metabolic analysis approach using gas chromatography-mass spectrometry (GC-MS) and established a method for simultaneous determination of 36 medium and long-chain fatty acids in the serum of mice. This method was validated for linearity, range, sensitivity, precision, accuracy, recovery, stability, and dilution integrity. The levels of most FA species and total FAs were increased in the HFD group (n = 9) compared with the lean group (n = 9). The principal component analysis (PCA) and the orthogonal partial least squares discriminant analysis (OPLS-DA) of all FA species were analyzed in both groups. We found that palmitic acid (16:0), stearic acid (18:0), oleic acid (18:1), and arachidonic acid (20:4) were significantly different (VIP>1, p<0.05 and FC>1.5) in the two groups. We also calculated serum indices measure the activities of different enzymes involved in fatty acid metabolism. The de novo lipogenesis index, elongase index, n-6 FAs, saturated FAs, unsaturated FAs, and SCD1 index 2 were increased in the HFD group compared with the lean group while the n-3 FAs, n-3/n-6 of the index, and SCD1 index 1 were decreased in the HFD group compared with the lean group. Relationships between major FA species and biochemical indicators (LDL-C, TC, TG, ALT, and AST) were evaluated by Pearson analysis. The serum FA concentrations (C16:0, C18:0, C18:1, and C20:4) and serum indices (De novo lipogenesis index, elongase index, saturated FAs, unsaturated FAs and n-6 FAs) positively correlated with LDL-C, TC, TG, ALT, and AST. Collectively, our study provides insights into NAFLD and its effect on lipid metabolism. [Display omitted] •A targeted metabolomic method for determination of 36 FAs in serum was established by GC-MS.•Serum concentrations of major FA species and indices are higher in NAFLD compared to controls.•C16:0, C18:0, C18:1, and C20:4 were served as potential biomarkers for differentiating NAFLD from control group.•The level of major FA species and indices in serum positively correlates with LDL-C, TC, TG, ALT and AST.</description><subject>Animals</subject><subject>Diet, High-Fat - adverse effects</subject><subject>Fatty acids</subject><subject>Fatty Acids - metabolism</subject><subject>Gas Chromatography-Mass Spectrometry</subject><subject>GC-MS</subject><subject>Lipid metabolism</subject><subject>Liver - metabolism</subject><subject>Metabolomics</subject><subject>Mice</subject><subject>Non-alcoholic fatty liver</subject><subject>Non-alcoholic Fatty Liver Disease - etiology</subject><subject>Non-alcoholic Fatty Liver Disease - metabolism</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kDGP1DAQhS0E4paDP0CBXNJk8diOk0g0aOHukA5RcEh01tiZgFdJvNjJSfvv8WoXSjTFNN970vsYew1iCwLMu_12f3C4lULKLYA2UjxhG2gbVUmjfzxlG9EoqBrR1lfsRc57IUQNnX7OrlQNUmttNuzwgOknLdTziRZ0cYxT8JkfUhzCSJlnSuvEB1yWI0cf-szdkd_dfORh7ldfYnOcKxx9_BXH4C_gGB4pFYKXLuIOc-HizG931ZdvL9mzAcdMry7_mn2_-fSwu6vuv95-3n24r7yqzVK15KQh2ZtO1K1vhKsdoZcKwDihFQxaO9NphEag7gTWoAAlom81EAKpa_b23Fum_F4pL3YK2dM44kxxzVaaclKJThVUnlGfYs6JBntIYcJ0tCDsybTd25NpezJtz6ZL6M2lf3UT9f8if9UW4P0ZoLLyMVCy2Qeai7OQyC-2j-F__X8A_zmOmA</recordid><startdate>20220320</startdate><enddate>20220320</enddate><creator>Yan, Xing</creator><creator>Li, Linnan</creator><creator>Liu, Pei</creator><creator>Xu, Jie</creator><creator>Wang, Zhengtao</creator><creator>Ding, Lili</creator><creator>Yang, Li</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220320</creationdate><title>Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS</title><author>Yan, Xing ; Li, Linnan ; Liu, Pei ; Xu, Jie ; Wang, Zhengtao ; Ding, Lili ; Yang, Li</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-8eb26e2d69058c70b5beac23116b0431f44b694a170a490a5131a2aac841ea1e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Diet, High-Fat - adverse effects</topic><topic>Fatty acids</topic><topic>Fatty Acids - metabolism</topic><topic>Gas Chromatography-Mass Spectrometry</topic><topic>GC-MS</topic><topic>Lipid metabolism</topic><topic>Liver - metabolism</topic><topic>Metabolomics</topic><topic>Mice</topic><topic>Non-alcoholic fatty liver</topic><topic>Non-alcoholic Fatty Liver Disease - etiology</topic><topic>Non-alcoholic Fatty Liver Disease - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yan, Xing</creatorcontrib><creatorcontrib>Li, Linnan</creatorcontrib><creatorcontrib>Liu, Pei</creatorcontrib><creatorcontrib>Xu, Jie</creatorcontrib><creatorcontrib>Wang, Zhengtao</creatorcontrib><creatorcontrib>Ding, Lili</creatorcontrib><creatorcontrib>Yang, Li</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yan, Xing</au><au>Li, Linnan</au><au>Liu, Pei</au><au>Xu, Jie</au><au>Wang, Zhengtao</au><au>Ding, Lili</au><au>Yang, Li</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>2022-03-20</date><risdate>2022</risdate><volume>211</volume><spage>114620</spage><epage>114620</epage><pages>114620-114620</pages><artnum>114620</artnum><issn>0731-7085</issn><eissn>1873-264X</eissn><abstract>Nonalcoholic fatty liver (NAFLD) is associated with metabolic abnormalities and changes in lipid processing. Fatty acids (FAs) are important signaling molecules in the body and are the main raw materials for lipid synthesis. To explore the lipidomic profile of serum fatty acids in mice, we put the mice on a high-fat diet (HFD) to induce NAFLD. We applied a targeted metabolic analysis approach using gas chromatography-mass spectrometry (GC-MS) and established a method for simultaneous determination of 36 medium and long-chain fatty acids in the serum of mice. This method was validated for linearity, range, sensitivity, precision, accuracy, recovery, stability, and dilution integrity. The levels of most FA species and total FAs were increased in the HFD group (n = 9) compared with the lean group (n = 9). The principal component analysis (PCA) and the orthogonal partial least squares discriminant analysis (OPLS-DA) of all FA species were analyzed in both groups. We found that palmitic acid (16:0), stearic acid (18:0), oleic acid (18:1), and arachidonic acid (20:4) were significantly different (VIP>1, p<0.05 and FC>1.5) in the two groups. We also calculated serum indices measure the activities of different enzymes involved in fatty acid metabolism. The de novo lipogenesis index, elongase index, n-6 FAs, saturated FAs, unsaturated FAs, and SCD1 index 2 were increased in the HFD group compared with the lean group while the n-3 FAs, n-3/n-6 of the index, and SCD1 index 1 were decreased in the HFD group compared with the lean group. Relationships between major FA species and biochemical indicators (LDL-C, TC, TG, ALT, and AST) were evaluated by Pearson analysis. The serum FA concentrations (C16:0, C18:0, C18:1, and C20:4) and serum indices (De novo lipogenesis index, elongase index, saturated FAs, unsaturated FAs and n-6 FAs) positively correlated with LDL-C, TC, TG, ALT, and AST. Collectively, our study provides insights into NAFLD and its effect on lipid metabolism. [Display omitted] •A targeted metabolomic method for determination of 36 FAs in serum was established by GC-MS.•Serum concentrations of major FA species and indices are higher in NAFLD compared to controls.•C16:0, C18:0, C18:1, and C20:4 were served as potential biomarkers for differentiating NAFLD from control group.•The level of major FA species and indices in serum positively correlates with LDL-C, TC, TG, ALT and AST.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>35124446</pmid><doi>10.1016/j.jpba.2022.114620</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0731-7085
ispartof Journal of pharmaceutical and biomedical analysis, 2022-03, Vol.211, p.114620-114620, Article 114620
issn 0731-7085
1873-264X
language eng
recordid cdi_proquest_miscellaneous_2626223093
source ScienceDirect Journals
subjects Animals
Diet, High-Fat - adverse effects
Fatty acids
Fatty Acids - metabolism
Gas Chromatography-Mass Spectrometry
GC-MS
Lipid metabolism
Liver - metabolism
Metabolomics
Mice
Non-alcoholic fatty liver
Non-alcoholic Fatty Liver Disease - etiology
Non-alcoholic Fatty Liver Disease - metabolism
title Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T19%3A01%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeted%20metabolomics%20profiles%20serum%20fatty%20acids%20by%20HFD%20induced%20non-alcoholic%20fatty%20liver%20in%20mice%20based%20on%20GC-MS&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Yan,%20Xing&rft.date=2022-03-20&rft.volume=211&rft.spage=114620&rft.epage=114620&rft.pages=114620-114620&rft.artnum=114620&rft.issn=0731-7085&rft.eissn=1873-264X&rft_id=info:doi/10.1016/j.jpba.2022.114620&rft_dat=%3Cproquest_cross%3E2626223093%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-8eb26e2d69058c70b5beac23116b0431f44b694a170a490a5131a2aac841ea1e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2626223093&rft_id=info:pmid/35124446&rfr_iscdi=true